Why Abzena?
Our focused approach.
Edward Cloake is a Director in Bioassay team at Abzena. He specializes in Immunogenicity with a successful track record of delivering immunogenicity risk assessment assays for a broad range of protein biotherapeutics.
Edward has over 17 years’ experience in the pre-clinical immunogenicity assessment of biologics. He leads a team that utilizes a range of assays to evaluate the presence of potential T cell epitopes, and subsequent mitigation strategies to de-risk candidates.